[1]
2025. Structural Elucidation And Pharmacophoric Evaluation Of Gsk Novel Nitro-Substituted Compound (4r). The Review of Diabetic Studies . (Oct. 2025), 745–756. DOI:https://doi.org/10.70082/mmcf3310.